Recovery of Neurological Function of Ischemic Stroke by Application of Conditioned Medium of Bone Marrow Mesenchymal Stem Cells Derived from Normal and Cerebral Ischemia Rats
Overview
Authors
Affiliations
Background: Several lines of evidence have demonstrated that bone marrow-derived mesenchymal stem cells (BM-MSC) release bioactive factors and provide neuroprotection for CNS injury. However, it remains elusive whether BM-MSC derived from healthy donors or stroke patients provides equal therapeutic potential. The present work aims to characterize BM-MSC prepared from normal healthy rats (NormBM-MSC) and cerebral ischemia rats (IschBM-MSC), and examine the effects of their conditioned medium (Cm) on ischemic stroke animal model.
Results: Isolated NormBM-MSC or IschBM-MSC formed fibroblastic like morphology and expressed CD29, CD90 and CD44 but failed to express the hematopoietic marker CD34. The number of colony formation of BM-MSC was more abundant in IschBM-MSC than in NormBM-MSC. This is in contrast to the amount of Ficoll-fractionated mononuclear cells from normal donor and ischemic rats. The effect of cm of BM-MSC was further examined in cultures and in middle cerebral artery occlusion (MCAo) animal model. Both NormBM-MSC Cm and IschBM-MSC Cm effectively increased neuronal connection and survival in mixed neuron-glial cultures. In vivo, intravenous infusion of NormBM-MSC Cm and IschBM-MSC Cm after stroke onset remarkably improved functional recovery. Furthermore, NormBM-MSC Cm and IschBM-MSC Cm increased neurogenesis and attenuated microglia/ macrophage infiltration in MCAo rat brains.
Conclusions: Our data suggest equal effectiveness of BM-MSC Cm derived from ischemic animals or from a normal population. Our results thus revealed the potential of BM-MSC Cm on treatment of ischemic stroke.
Razavi-Toosi S, Asadi Y, Aboutaleb N, Faezi M Basic Clin Neurosci. 2024; 14(6):843-856.
PMID: 39070200 PMC: 11273199. DOI: 10.32598/bcn.2023.5693.1.
Nuszkiewicz J, Kukulska-Pawluczuk B, Piec K, Jarek D, Motolko K, Szewczyk-Golec K J Clin Med. 2024; 13(14).
PMID: 39064298 PMC: 11278353. DOI: 10.3390/jcm13144258.
Jang E, Yu H, Kim E, Hwang J, Yoo J, Choi J Int J Mol Sci. 2024; 25(12).
PMID: 38928069 PMC: 11203670. DOI: 10.3390/ijms25126362.
Ling Y, Ramalingam M, Lv X, Niu D, Zeng Y, Qiu Y J Mol Histol. 2024; 55(3):329-348.
PMID: 38609527 DOI: 10.1007/s10735-024-10192-7.
The Role of Stem Cells as Therapeutics for Ischaemic Stroke.
Ya J, Pellumbaj J, Hashmat A, Bayraktutan U Cells. 2024; 13(2).
PMID: 38247804 PMC: 10814781. DOI: 10.3390/cells13020112.